Heron Therapeutics, Inc. /DE/ SEC filings HRTX
Heron Therapeutics, Inc. /DE/ has 1,000 filings in SEC EDGAR's recent list, going back to Jun 2, 2011. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| S-8 | Employee stock plan registration | Oct 27, 2026 | — |
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 29, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Aug 14, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 31, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 19, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 19, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 19, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 25, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 6, 2026 |
| 8-K |
Current report
Other events
|
Jun 2, 2026 | Jun 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 19, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 19, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 19, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2026 | Apr 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 30, 2026 | — |
| 4 | Insider transaction | Jan 20, 2026 | Jan 19, 2026 |
| 4 | Insider transaction | Jan 20, 2026 | Jan 19, 2026 |
| 4 | Insider transaction | Jan 20, 2026 | Jan 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 26, 2025 | — |
| 4 | Insider transaction | Nov 12, 2025 | Nov 8, 2025 |
| 3 | Initial insider ownership | Nov 7, 2025 | Oct 27, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Oct 31, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Oct 31, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Oct 31, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 29, 2025 | Oct 27, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 19, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 19, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 19, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 17, 2025 | — |
| 4 | Insider transaction | Oct 17, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 15, 2025 | Oct 15, 2025 |
| DEF 14A | Proxy statement | Sep 19, 2025 | Oct 13, 2025 |
| EFFECT | Filing | Sep 16, 2025 | — |
| EFFECT | Filing | Sep 16, 2025 | — |
| CORRESP | Letter to the SEC | Sep 12, 2025 | — |
| CORRESP | Letter to the SEC | Sep 12, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| S-3 | Shelf registration | Sep 9, 2025 | — |
| S-3 | Shelf registration | Sep 9, 2025 | — |
| PRE 14A | Preliminary proxy statement | Sep 9, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 28, 2025 | Aug 22, 2025 |
| 8-A12B | Filing | Aug 15, 2025 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 15, 2025 | Aug 13, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 12, 2025 | — |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Other events
|
Aug 12, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 12, 2025 | Aug 6, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Other events
|
Aug 8, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Jul 19, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 19, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 19, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 19, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 6, 2025 |
| S-8 | Employee stock plan registration | May 6, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Other events
|
May 6, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Apr 29, 2025 | Apr 28, 2025 |
| 3 | Initial insider ownership | Apr 29, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2025 | Apr 28, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 19, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 19, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 19, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 3, 2025 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 20, 2025 | Feb 13, 2025 |
| 4/A | Filing | Feb 4, 2025 | Jan 31, 2025 |
| 4/A | Filing | Feb 4, 2025 | Jan 31, 2025 |
| 4/A | Filing | Feb 4, 2025 | Jan 31, 2025 |
| 4/A | Filing | Feb 4, 2025 | Jan 31, 2025 |
| 4/A | Filing | Feb 4, 2025 | Jan 31, 2025 |
| 4/A | Filing | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Feb 3, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 19, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 19, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Other events
|
Dec 3, 2024 | Dec 3, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 4 | Insider transaction | Nov 6, 2024 | Nov 4, 2024 |
| 3 | Initial insider ownership | Nov 5, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| 4 | Insider transaction | Oct 21, 2024 | Oct 19, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 19, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 19, 2024 |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 19, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 19, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 18, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 16, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 6, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | May 31, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 19, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 19, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 19, 2024 |
| 4 | Insider transaction | Apr 5, 2024 | Apr 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2024 | Mar 18, 2024 |
| 10-K | Annual report | Mar 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2024 | Mar 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 24, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 19, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HRTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 818033
- Former names
- AP PHARMA INC /DE/ (until Jan 7, 2014); ADVANCED POLYMER SYSTEMS INC /DE/ (until Apr 6, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.